Table 3.
Phenotypic resistance of isolated microorganisms (efficacy population)
| Microorganism | Resistance status | |||
|---|---|---|---|---|
|
Streptococcus pneumoniae
|
Penicillin-R* |
Penicillin-I* |
Penicillin-S* |
Not available |
|
n = 217 (100%) |
27/217 (12.4%) |
2/217 (2.3%) |
69/217 (31.8%) |
116/217 (53.5%) |
|
Haemophilus influenzae
|
β-lactamase pos. |
--- |
β-lactamase neg. |
Not available |
|
n = 90 (100%) |
6/90 (6.7%) |
|
20/90 (22.2%) |
64/90 (71.3%) |
|
Moraxella catarrhalis
|
β-lactamase pos. |
--- |
β-lactamase neg. |
Not available |
|
n = 19 (100%) |
2/19 (10.5%) |
|
3/19 (15.8%) |
15/19 (73.7%) |
|
Staphylococcus aureus
|
MRSA |
--- |
MSSA |
Not available |
|
n = 62 (100%) |
2/62 (3.2%) |
17/62 (21.4%) |
41/62 (66.1%) |
|
|
Oxacillin-R |
|
Oxacillin-S |
|
|
| 0/62 (0%) |
2/62 (3.2%) |
|
||
|
Enterobacteriaceae spp. |
ESBL producer |
--- |
Non-ESBL producer |
Not available |
| n = 211 (100%) | 2/111 (1.8%) | 11/111 (9.9%) | 98/111 (88.3%) | |
*R, I, S = resistant, intermediate resistant, sensitive, respectively. ESBL, extended-spectrum β-lactamase; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus.